Italia markets closed
Dow Jones
37.775,38 +22,07 (+0,06%) Nasdaq
15.601,50 -81,87 (-0,52%) Nikkei 225
38.079,70 +117,90 (+0,31%) EUR/USD
1,0645 -0,0030 (-0,28%) Bitcoin EUR
59.676,73 +2.015,71 (+3,50%) CMC Crypto 200
885,54 0,00 (0,00%)
PTC Therapeutics, Inc. (PTCT)
NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 04:00PM EDT
Dopo ore:
| Chiusura precedente | 25,16 |
| Aperto | 25,01 |
| Denaro | 24,67 x 100 |
| Lettera | 31,47 x 100 |
| Min-Max giorno | 24,47 - 25,26 |
| Intervallo di 52 settimane | 17,53 - 59,84 |
| Volume | |
| Media Volume | 911.766 |
| Capitalizzazione | 1,891B |
| Beta (5 anni mensile) | 0,67 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -8,37 |
| Prossima data utili | 25 apr 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 27,91 |
GlobeNewswireSensorium Therapeutics Appoints Veteran Life Sciences Executive Mr. David Southwell to its Board of Directors
BOSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Sensorium Therapeutics (Sensorium), a biotechnology company translating insights from nature and human experience to deliver transformational therapeutics, today announced the appointment of veteran life sciences executive David Southwell to its Board of Directors. “We are excited to welcome David to our Board,” said Dick Simon, Chief Executive Officer of Sensorium. “He is a seasoned life sciences executive with a track record of success that spans mult
© 2024 Yahoo. Tutti i diritti riservati.